Clinical Trial Update: Efficacy and Safety of HB-1 for Panic Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of HB-1 for panic disorder is currently recruiting, sponsored by HB BioTech, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Drugs mentioned

• HB-1

Snippet

Sponsor: HB BioTech, LLC | Conditions: Panic Disorder, Mental Illness | Phase 2 | Status: RECRUITING